ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 117 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,090 | +2.3% | 5,837 | +43.9% | 0.01% | +25.0% |
| Q2 2023 | $114,448 | +80.8% | 4,057 | +10.2% | 0.00% | +33.3% |
| Q1 2023 | $63,313 | -25.2% | 3,681 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $84,626 | +7.1% | 3,681 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $79,000 | +2.6% | 3,681 | +33.8% | 0.00% | +33.3% |
| Q2 2022 | $77,000 | -39.4% | 2,752 | 0.0% | 0.00% | -40.0% |
| Q1 2022 | $127,000 | -45.0% | 2,752 | 0.0% | 0.01% | -37.5% |
| Q4 2021 | $231,000 | +26.2% | 2,752 | 0.0% | 0.01% | +14.3% |
| Q3 2021 | $183,000 | +31.7% | 2,752 | +5.6% | 0.01% | +40.0% |
| Q2 2021 | $139,000 | +33.7% | 2,607 | +8.3% | 0.01% | +25.0% |
| Q1 2021 | $104,000 | -16.8% | 2,408 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $125,000 | +316.7% | 2,408 | +163.7% | 0.01% | +500.0% |
| Q3 2020 | $30,000 | -31.8% | 913 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $44,000 | – | 913 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |